Ghe, LLC Abbott Laboratories Transaction History

Ghe, LLC

$267 Million
Q3 2024

A detailed history of Ghe, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ghe, LLC holds 14,472 shares of ABT stock, worth $1.65 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

14,472

Previous 12,601 14.85%

Holding current value

$1.65 Million

Previous $1.31 Million 26.05%

% of portfolio

0.62%

Previous 0.53%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$100.07 - $118.13 $187,230 - $221,021	1,871 Added 14.85%	14,472 $1.65 Million
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $604 - $674	6 Added 0.05%	12,601 $1.31 Million
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $5,256 - $5,806	48 Added 0.38%	12,595 $1.43 Million
Q4 2023 Feb 02, 2024	BUY	$90.19 - $110.4 $16,414 - $20,092	182 Added 1.47%	12,547 $1.38 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $15,093 - $18,109	158 Added 1.29%	12,365 $1.2 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $23,827 - $28,046	246 Added 2.06%	12,207 $1.24 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $53,803 - $63,120	566 Added 4.97%	11,961 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $176,393 - $204,230	1,823 Added 19.05%	11,395 $1.1 Million
Q2 2022 Jul 20, 2022	SELL	$102.07 - $123.37 $174,437 - $210,839	-1,709 Reduced 15.15%	9,572 $1.13 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $39,222 - $47,829	344 Added 3.15%	11,281 $1.34 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $1.26 Million - $1.55 Million	10,937 New	10,937 $1.54 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghe, LLC with notifications on news.

Account